Evidence map›Paper›PMID 36930792›Full record

ReviewJournal of clinical laboratory analysis2023

Leukemic phase follicular lymphoma in a young adult.

Daniel Rivera, Wei Wang, Zubaidah Al-Jumaili, Zhihong Hu

Open access · goldAbstract readReviewCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical laboratory analysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Leukemic phase follicular lymphoma in a young adult.Journal of clinical laboratory analysis · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniel RiveraDepartment of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-1949-0674
Wei WangDepartment of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Zubaidah Al-JumailiDepartment of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Zhihong HuDepartment of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
The University of Texas Health Science Center at Houston · USThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeukemic presentation of follicular lymphoma (FL) is uncommon, with most cases reported in older adults.

designThis report describes an unusual case of a young adult diagnosed with leukemic phase of FL. We reviewed the existing literature on this rare presentation of the disease and its potential impact on patient outcomes.

resultsLeukemic phase of FL in young adults can be mistaken for other high-grade hematologic malignancies. Morphology assessment and ancillary testing, such as flow cytometry and FISH analysis, can assist in achieving an accurate diagnosis of the leukemic phase of FL. Notably, our young patient responded well to therapy, which is different from what is typically observed in older patients who have a poorer prognosis. Further cases are needed to investigate the prognostic impact of the leukemic phase of FL in younger patients.

Indexed as

Lymphoma, FollicularHumansIn Situ Hybridization, FluorescencePrognosisProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-2BCL2 rearrangementfollicular lymphomaleukemic phaselymphocytosis

Identifiers

PMID36930792
PMCPMC10098048
OpenAlexW4327711708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.